Error loading player: No playable sources found

Session V: Multispecifics and ADCs Characterization

Date
September 12, 2024
This product is not available for individual purchase, but it is available as part of the following products:

Session Chairs: Chris Chumsae, Bristol-Myers Squibb Company and Frances Namuswe, CDER, FDA


Session Speakers:


Glyco-Analysis of a Glycoengineered VHH-Radioligand Therapy Designed for Improved Biodistribution

David Bush, Novartis 


Characterization of ADCs in Serum and Formulation Buffer

Tun Liu, Johnson & Johnson


Development of Novel Chromatographic and Mass Spectrometric Techniques for Characterizations of BsAbs and ADCs

Fengfei Ma, Merck & Co., Inc.  


Related Products

Thumbnail for Session II: Mass Spectrometry in Cell & Gene Therapy
Session II: Mass Spectrometry in Cell & Gene Therapy
Session Chairs: : Rich Rogers,_ Umoja Biopharma_ and Chris Yu, _Genentech, __A Member of the Roche Group_
Thumbnail for Lunch and Learn Technical Seminar presented by Agilent Technologies, Inc.
Lunch and Learn Technical Seminar presented by Agilent Technologies, Inc.
STRATEGIES FOR EXPEDITED CHARACTERIZATION OF HIGHER ORDER STRUCTURE: MICRODROPLET REACTIONS COUPLED TO ION MOBILITY WITH COLLISION INDUCED UNFOLDING AND ELECTRON CAPTURE DISSOCIATION…
Thumbnail for Session VIII: MAM for Product & Process Characterization & Quality Control
Session VIII: MAM for Product & Process Characterization & Quality Control
Session Chairs: Ingo Lindner,_ Roche Diagnostics GmbH_ and Da Ren, _BioTherapeutics Solutions_